What is the mechanism by which Kratom (mitragyna speciosa) causes hyperpigmentation?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 26, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Mechanism of Kratom-Induced Hyperpigmentation

Kratom (Mitragyna speciosa) causes hyperpigmentation through direct deposition of the drug and its metabolites in the skin, particularly in sun-exposed areas, similar to other drug-induced pigmentation disorders. 1

Pathophysiological Mechanism

Kratom-induced hyperpigmentation occurs through several potential mechanisms:

  1. Drug Deposition:

    • Kratom alkaloids and their metabolites accumulate in the skin, particularly in dermal macrophages
    • This accumulation is often worsened by sun exposure, which can transform the drug into visible particles 2
  2. Melanin Interaction:

    • Kratom compounds may form complexes with melanin
    • Sun exposure stimulates melanin synthesis, exacerbating the pigmentation process 2
  3. Photosensitivity:

    • Similar to other drugs that cause photosensitivity reactions, kratom may increase skin sensitivity to UV radiation
    • This leads to a photodistributed pattern of hyperpigmentation, primarily affecting sun-exposed areas 1

Clinical Presentation

Kratom-induced hyperpigmentation typically presents as:

  • Diffuse, photodistributed hyperpigmentation
  • Primarily affects sun-exposed areas of the skin
  • Develops after chronic, long-term use (often after years of regular consumption)
  • May persist even after discontinuation of kratom 1

Risk Factors

Several factors increase the risk of developing kratom-induced hyperpigmentation:

  • Duration of use: Long-term, chronic use (often >1 year)
  • Dosage: Higher doses may increase risk
  • Sun exposure: UV radiation exacerbates the condition
  • Individual susceptibility: Genetic factors may play a role

Management Considerations

The FDA warns against the use of kratom due to its potential for serious adverse effects, including hyperpigmentation 3. The Society for Perioperative Assessment and Quality Improvement (SPAQI) does not recommend the use of kratom and advises discontinuation 3.

For patients who have already developed kratom-induced hyperpigmentation:

  1. Primary intervention:

    • Discontinue kratom use
    • Strict sun protection with broad-spectrum SPF 70 or higher 4
  2. Treatment options:

    • The 730-nm picosecond titanium-sapphire laser has shown promising results in treating kratom-induced hyperpigmentation 5
    • Standard hyperpigmentation treatments may be considered, including:
      • Topical agents (hydroquinone, triple combination creams)
      • Chemical peels
      • Laser therapy (with caution in darker skin types) 4

Important Considerations

  • Kratom-induced hyperpigmentation may persist for extended periods or become permanent in some cases 2
  • The FDA has warned against kratom use due to multiple safety concerns, including its opioid-like properties and potential for addiction 3, 6
  • Kratom has been associated with other serious adverse effects including seizures and neurological consequences 6

Prevention

The most effective prevention strategy is to avoid kratom use entirely, as recommended by the SPAQI 3. For those who continue to use kratom despite warnings, minimizing sun exposure and using sun protection may help reduce the risk of developing hyperpigmentation.

References

Research

Drug-induced skin pigmentation. Epidemiology, diagnosis and treatment.

American journal of clinical dermatology, 2001

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Platelet-Rich Plasma Therapy

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Kratom: The safe legal high?

Epilepsy & behavior : E&B, 2021

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.